摘要
Triple-negative breast cancer(TNBC)has a poor prognosis because of its aggressive behavior,absence of specific therapies,and high recurrence.1 The exact molecular mechanisms that drive the progression of TNBC are not yet fully understood,thus highlighting the urgent need for discovering novel potential treatment targets.
基金
supported by the National Natural Science Foundation of China(No.82072923,82102829)
Zhejiang Provincial Medical Science and Technology Program(China)(No.2020KY903).
